It was reported that PYCR1 silencing could inhibit the expression of insulin receptor substrate 1 (IRS1) and insulin resistance via the suppression of the c‐Jun N‐terminal kinase (JNK) signaling pathway, which subsequently inhibited HCC cell proliferation and promoted cell apoptosis 23. Here, IRS1 is linked to hepatocellular carcinoma.